Schisandra (Liver Focus).

Silymarin acts on the hepatocyte membrane and glutathione levels while schisandra lignans induce phase II conjugation enzymes. The pairing covers structure and enzyme capacity rather than duplicating one.

Schisandra lignans raise glutathione synthesis through Nrf2, and cysteine supplied as NAC is the rate limiting input to that synthesis. Demand and substrate move together.

Curcumin and schisandrin both activate the Nrf2 pathway that drives glutathione S-transferase and other phase II enzymes. Two structurally unrelated inputs converge on one transcription programme.

Sulforaphane from broccoli sprouts is among the strongest known Nrf2 activators, the same pathway schisandra lignans engage. Combining them raises phase II conjugation capacity.

Cynarin from artichoke leaf supports bile production and flow, the export route for what phase II conjugation attaches to. Schisandra acts on the enzyme side, artichoke on the outflow.

Taurine is one of the two amino acids bile acids are conjugated with, keeping bile soluble and flowing. It supports the export end of the pathway schisandra pushes at the enzyme end.

Selenium sits in the active site of glutathione peroxidase, the enzyme that spends glutathione on peroxide handling. Without it the enlarged glutathione pool cannot be used efficiently.

Lipoic acid returns oxidised glutathione to its reduced form, so the pool schisandra helps build stays functional for longer. Synthesis and regeneration are separate levers.

Betaine donates a methyl group to regenerate methionine and keeps hepatic SAMe available, and SAMe is required for methylation reactions and for the transsulfuration route toward glutathione. That supports the conjugation capacity schisandra induces.

SAMe drives hepatic methylation reactions and feeds the transsulfuration route toward cysteine and glutathione. Schisandra raises the enzymes that spend those products.

Glycine is ligated onto gamma-glutamylcysteine in the second step of glutathione synthesis. It is also the conjugating amino acid for bile acid amidation. Both processes sit in the same hepatic compartment this ingredient is formulated around, so the pairing is substrate chemistry rather than a tested combination.

Glutamine is deamidated to glutamate, which is the first amino acid in the glutathione tripeptide. Where a formula leans on conjugation capacity, glutamate supply is part of the substrate picture. This is precursor biochemistry and not a claim about the pair in people.

Glutathione reductase uses FAD, which is derived from riboflavin, to return oxidised glutathione to its reduced form. Without that recycling step the pool depletes under oxidative load. Textbook cofactor chemistry, no citation needed and no claim about schisandra implied.

Cystathionine beta-synthase and cystathionine gamma-lyase both require pyridoxal-5-phosphate. That pathway is how methionine sulfur reaches cysteine, the rate-limiting glutathione precursor. The link is settled one-carbon and transsulfuration biochemistry.

5-methyltetrahydrofolate donates the methyl group that remethylates homocysteine to methionine, which is then adenosylated to SAM-e. SAM-e is already stored against this ingredient, and folate sits directly upstream of it. This is established one-carbon metabolism.

Methionine synthase requires methylcobalamin to transfer the folate-derived methyl group onto homocysteine. Folate and B12 are jointly rate-setting for that step. Standard biochemistry, sitting upstream of the methylation and conjugation capacity these formulas are built around.

Choline is oxidised to betaine, which is the alternative methyl donor for homocysteine remethylation, running in parallel to the folate route already covered by the stored TMG row. Choline is also needed for phosphatidylcholine synthesis and therefore for VLDL export of hepatic lipid. Both are established pathways, not effects of the pair.

Phosphatidylcholine is a required structural component of the lipoprotein particles that export triglyceride out of the liver. It also emulsifies lipophilic lignans, which improves their dispersion in the gut. Two separate established mechanisms make the pairing sensible in a formula of this kind.

Ascorbate handles the water compartment and regenerates oxidised tocopherol at the membrane interface, while schisandra lignans are lipophilic. The compartments differ, which is why the two are placed together. This is redox chemistry rather than a combination result.

Alpha-tocopherol terminates lipid radical chains inside membranes, the same environment where lipophilic lignans distribute. Formulas aimed at membrane lipid protection combine them for that reason. The grounding is settled antioxidant chemistry.

Zinc is a structural cofactor for copper-zinc superoxide dismutase and induces metallothionein, a cysteine-rich metal-binding protein made in the liver. Both sit in the antioxidant defence layer these formulas address. Cofactor chemistry only, with no schisandra-specific claim.

Both glutamate-cysteine ligase and glutathione synthetase are ATP-dependent, and ATP works as a magnesium complex. Methionine adenosyltransferase, which makes SAM-e, is likewise magnesium-dependent. The link is enzyme cofactor chemistry, plain and settled.

Dandelion root is a long-standing bitter used to encourage bile flow, and monographs describe a choleretic action. Placed with schisandra it targets a different lever, bile movement rather than antioxidant signalling. The grounding is monograph and traditional use, not a combination trial.

Bile acids form the mixed micelles that carry fat-soluble compounds across the unstirred water layer to the enterocyte. Schisandra lignans are fat-soluble and depend on that route. This is standard absorption physiology and a plausible formulation pairing, not a measured increase in lignan uptake.

Quercetin and schisandra lignans are both glucuronidated by overlapping UGT isoforms. Co-dosing loads the same conjugation capacity, which can raise the exposure of either. Regard this as a real handling interaction, described from enzyme work rather than measured in people taking both.

Catechins and lignans both engage Nrf2-linked antioxidant response signalling in cell models and both are conjugated before excretion. The overlap is genuine on both axes. High-dose concentrated catechin extracts also carry their own hepatic monitoring considerations, which is worth counting when stacking.

Both compounds activate Nrf2-driven transcription in cell and rodent systems and both are heavily glucuronidated on first pass. The pairing is common in hepatic-support blends. The evidence base is preclinical, so this is a mechanism row rather than a human finding.

Sulfite oxidase requires the molybdenum cofactor to convert sulfite to sulfate, the terminal step of sulfur amino acid catabolism. Formulas that push cysteine and methionine substrate load through that pathway rely on it. Settled cofactor biochemistry.